Director, Companion Animal Veterinary Services
Ceva Animal Health, LLC, United States
Susanne Heartsill is a 1999 graduate of Mississippi State University College of Veterinary Medicine and is the founder of Downtown Animal Hospital in Memphis, Tennessee.
Dr. Heartsill currently serves as the Director of US Companion Animal Veterinary Services at Ceva Animal Health.
Dr. Heartsill joined Ceva as a Veterinary Services Manager and Level 3, Fear Free Certified Veterinarian in 2018. In 2020, Dr. Heartsill became the U.S. Cardiology Technical Marketing Manager for Ceva. In this role, she spearheaded the creation and implementation of cardiology education for the U.S. commercial team in preparation for the launch of CARDALIS™. She has authored and co-authored multiple publications. In 2021, she completed credentialling and is a Diplomate of the American Board of Veterinary Practitioners (DABVP) in Canine and Feline Practice. In early 2022, Dr. Heartsill was promoted to Director of US Companion Animal Veterinary Services at Ceva Animal Health.
While running her busy small animal practice, Dr. Heartsill served as a key opinion leader for several veterinary advisory councils including Virbac, Q-biotics, and Novartis Animal Health and has been a Regional Field Advocate for IDEXX Laboratories. She has lectured nationally on topics ranging from inventory control and pharmacy management to cardiology, parasitology, laser surgery, behavior, dermatology, pancreatitis and zoonotic diseases.
Dr. Heartsill was recognized by the Memphis Business Journal as one of Memphis' Top 40 under 40 and holds a city sponsored beautification award by the Memphis Blue Suede Brigade for her part in real estate and business revitalization in the Memphis Pinch District.
Now residing with her family on their hobby farm outside of Auburn, Alabama, Dr. Heartsill enjoys horseback riding, farm life, and the great outdoors.
Disclosure information not submitted.
Knowledge Corner: FDA Conditional Approval: Lessons learned from PANOQUELL-CA1
Thursday, June 6, 2024
12:30pm – 12:55pm CT
Industry Session Breakfast: Updates in Pancreatitis: Innovation and PANOQUELL-CA1
Saturday, June 8, 2024
6:30am – 7:45am CT